(2E)-1-[3-methyl-4-(piperidin-4-yloxy)-1-benzofuran-2-yl]-3-phenylprop-2-en-1-one | 1402930-54-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (2E)-1-[3-methyl-4-(piperidin-4-yloxy)-1-benzofuran-2-yl]-3-phenylprop-2-en-1-one
• CAS: 1402930-54-4
• 化学式: C₂₈H₃₁NO₅
• 分子量: 461.558
• InChiKey: KMQMJLAAXWMGTR-BUHFOSPRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.42
• 重原子数：
  34.0
• 可旋转键数：
  5.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  68.98
• 氢给体数：
  0.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  (2E)-1-[3-methyl-4-(piperidin-4-yloxy)-1-benzofuran-2-yl]-3-phenylprop-2-en-1-one 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以14.7 mg的产率得到(2E)-1-[3-methyl-4-(piperidin-4-yloxy)-1-benzofuran-2-yl]-3-phenylprop-2-en-1-one
  参考文献：
  名称：

  Design and Synthesis of Inhibitors of Plasmodium falciparumN-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery

  摘要：

  Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum, the most lethal species of parasites that cause malaria, is described. Chemistry-driven optimization of compound 1 from a focused NMT inhibitor library led to the identification of two early lead compounds 4 and 25, which showed good enzyme and cellular potency and excellent selectivity over human NMT. These molecules provide a valuable starting point for further development.

  DOI：

  10.1021/jm301160h
• 作为产物：
  描述：

  N-Boc-4-羟基哌啶 在 偶氮二甲酸二异丙酯 、 三苯基膦 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 7.0h， 生成 (2E)-1-[3-methyl-4-(piperidin-4-yloxy)-1-benzofuran-2-yl]-3-phenylprop-2-en-1-one
  参考文献：
  名称：

  Design and Synthesis of Inhibitors of Plasmodium falciparumN-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery

  摘要：

  Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum, the most lethal species of parasites that cause malaria, is described. Chemistry-driven optimization of compound 1 from a focused NMT inhibitor library led to the identification of two early lead compounds 4 and 25, which showed good enzyme and cellular potency and excellent selectivity over human NMT. These molecules provide a valuable starting point for further development.

  DOI：

  10.1021/jm301160h

文献信息

• [EN] NOVEL COMPOUNDS AND THEIR USE IN THERAPY<br/>[FR] NOUVEAUX COMPOSÉS ET LEUR UTILISATION EN THÉRAPIE
  申请人：IMP INNOVATIONS LTD

  公开号：WO2013083991A1

  公开（公告）日：2013-06-13

  The invention provides compounds which inhibit N-myristoyltransferase and are selective for protozoal N-myristoyltransferase and, consequently suitable to treat microbial infections, including viral and fungal infections, and protozoan infections such as malaria, leishmaniasis and sleeping sickness.

  这项发明提供了抑制N-肉豆蔻酰基转移酶并且对原生动物N-肉豆蔻酰基转移酶具有选择性的化合物，因此适用于治疗微生物感染，包括病毒和真菌感染，以及疟疾、利什曼病和睡眠病等原生动物感染。